These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37235113)

  • 1. Clinical course and prognostic factors of COVID-19 infection in patients with chronic inflammatory-rheumatic disease: A retrospective, case-control study.
    Nas K; Güçlü E; Keskin Y; Dilek G; Kalçık Unan M; Can N; Tekeoğlu İ; Kamanlı A
    Arch Rheumatol; 2023 Mar; 38(1):44-55. PubMed ID: 37235113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
    Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
    Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
    Bakasis AD; Mavragani CP; Boki KA; Tzioufas AG; Vlachoyiannopoulos PG; Stergiou IE; Skopouli FN; Moutsopoulos HM
    J Autoimmun; 2021 Sep; 123():102687. PubMed ID: 34311142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.
    D'Silva KM; Serling-Boyd N; Wallwork R; Hsu T; Fu X; Gravallese EM; Choi HK; Sparks JA; Wallace ZS
    Ann Rheum Dis; 2020 Sep; 79(9):1156-1162. PubMed ID: 32457048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
    Isnardi CA; Roberts K; Saurit V; Petkovic I; Báez RM; Quintana R; Tissera Y; Ornella S; D Angelo Exeni ME; Pisoni CN; Castro Coello VV; Berbotto G; Haye Salinas MJ; Velozo E; Reyes Torres ÁA; Tanten R; Zelaya MD; Gobbi C; Alonso CG; de Los Ángeles Severina M; Vivero F; Paula A; Cogo AK; Alle G; Pera M; Nieto RE; Cosatti M; Asnal C; Pereira D; Albiero JA; Savio VG; Maldonado FN; Gamba MJ; Germán NF; Baños A; Gallino Yanzi J; Gálvez Elkin MS; Morbiducci JS; Martire MV; Maldonado Ficco H; Schmid MM; Villafañe Torres JA; de Los Ángeles Correa M; Medina MA; Cusa MA; Scafati J; Agüero SE; Lloves Schenone NM; Soriano ER; Graf C; Pons-Estel BA; Gomez G; Landi M; De la Vega MC; Pons-Estel GJ;
    Clin Rheumatol; 2023 Feb; 42(2):563-578. PubMed ID: 36201124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases.
    Alzahrani ZA; Alghamdi KA; Almaqati AS
    Rheumatol Int; 2021 Jun; 41(6):1097-1103. PubMed ID: 33856543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population.
    Arleo T; Tong D; Shabto J; O'Keefe G; Khosroshahi A
    Clin Rheumatol; 2021 Jul; 40(7):2633-2642. PubMed ID: 33420870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews.
    Karaarslan F; Demircioğlu Güneri F; Kardeş S
    Rheumatol Int; 2021 Jul; 41(7):1263-1271. PubMed ID: 33978818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection in children with rheumatic disease: Experience of a tertiary referral center.
    Sözeri B; Demir F; Kalın S; Hasbal Akkuş C; Salı E; Çakır D
    Arch Rheumatol; 2021 Sep; 36(3):381-388. PubMed ID: 34870170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional study of COVID-19 infection in patients with rheumatic diseases in a sample of a Damascene population, Syria.
    Khalayli N; Kudsi M
    Ann Med Surg (Lond); 2023 Apr; 85(4):689-693. PubMed ID: 37113876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study.
    Zhong J; Shen G; Yang H; Huang A; Chen X; Dong L; Wu B; Zhang A; Su L; Hou X; Song S; Li H; Zhou W; Zhou T; Huang Q; Chu A; Braunstein Z; Rao X; Ye C; Dong L
    Lancet Rheumatol; 2020 Sep; 2(9):e557-e564. PubMed ID: 32838309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Mortality in Patients with Rheumatic Diseases: A Real Concern.
    Al-Adhoubi NK; Ali M; Wahshi HA; Salmi IA; Al-Balushi F; Lawati TA; Mohammed A; Muqbali AA; Kalbani HA; Al-Abrawi S; Khamis F
    Curr Rheumatol Rev; 2022; 18(3):234-242. PubMed ID: 35418287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
    Montero F; Martínez-Barrio J; Serrano-Benavente B; González T; Rivera J; Molina Collada J; Castrejón I; Álvaro-Gracia J
    Rheumatol Int; 2020 Oct; 40(10):1593-1598. PubMed ID: 32794113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study.
    Fredi M; Cavazzana I; Moschetti L; Andreoli L; Franceschini F;
    Lancet Rheumatol; 2020 Sep; 2(9):e549-e556. PubMed ID: 32838307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
    Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
    Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the outcomes of SARS-CoV-2 infection in children and young people followed at Portuguese pediatric rheumatology clinics.
    Melo AT; Bernardo M; Pinheiro F; Rodrigues M; Torres R; Mourão AF; Carvalho S; Nascimento J; Sousa S; Santos MJ; Soares C; Cabral M; Marques RC; Reis PC; Ramos FO
    ARP Rheumatol; 2022 Oct; 1(ARP Rheumatology, nº3 2022):205-209. PubMed ID: 36056926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
    Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of COVID-19 in Inflammatory Rheumatic Diseases: A Retrospective Cohort Study.
    Alhowaish TS; Alhamadh MS; Alhabeeb AY; Aldosari SF; Masuadi E; Alrashid A
    Cureus; 2022 Jun; 14(6):e26343. PubMed ID: 35903564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.